ISRCTN99532788已完成未知
Study of the effect of trimetazidine MR 35 mg (2 tabs/day) on the emergence of choroidal neovascularisation in age-related macular degeneration: a multicentre, randomised, double-blind, placebo-controlled, phase III study in 1100 patients treated for 3 to 5 years
Institut de Recherches Internationales Servier (France)0 个研究点目标入组 1,100 人开始时间: 2009年4月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Male and female
- •2. Caucasian
- •3. Aged 55 to 83 years with age-related macular degeneration
- •4. Neovascularisation on the first eye
排除标准
- •1. Cataract
- •2. Diabetic retinopathy
- •3. Optical neuropathy
- •4. Neovascularisation on the studied eye
研究者
相似试验
尚未招募
3 期
Investigation of the effect of Trimetazidine in patients with Aluminum phosphide poisoningIRCT20211017052794N1Shahid Beheshti University of Medical Sciences30
进行中（未招募）
1 期
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.Patients with Angina pectoris having been treated by Percutaneous Coronary InterventionMedDRA version: 16.1Level: PTClassification code 10002383Term: Angina pectorisSystem Organ Class: 10007541 - Cardiac disordersEUCTR2010-022134-89-GRI.R.I.S.10,300
进行中（未招募）
1 期
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.EUCTR2010-022134-89-LVI.R.I.S.10,300
撤回
3 期
The efficAcy and safety of Trimetazidine in Patients with angina pectoris having been treated by percutaneous Coronary Intervention. ATPCI study An international, multicentre, randomised, double-blind, placebo-controlled study in patients treated for 2 to 4 years.chest painspasm of the heart10011082NL-OMON38975Servier200
进行中（未招募）
不适用
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.EUCTR2010-022134-89-EEI.R.I.S.10,300